Jove
Visualize
Contact Us

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

44
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
44
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

31
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
31
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

28
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
28
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

45
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
45
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

45
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
45
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

60
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
60

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of influenza vaccination on in-hospital outcomes among patients with heart failure and acute respiratory illness.

American heart journal plus : cardiology research and practice·2026
Same author

Blood Pressure Variability (BPV) as a Novel Digital Biomarker of Multisystem Risk and Diagnostic Insight: Measurement, Mechanisms, and Emerging Artificial Intelligence Methods.

Biomedicines·2026
Same author

Therapeutic advances with KRAS<sup>G12C</sup> inhibitors and combination strategies in non-small cell lung cancer brain metastases.

Cancer gene therapy·2026
Same author

SAHVAI-3D and 4D: Automated AI Volumetric Measurement of Subarachnoid Hemorrhage on Noncontrast Head CT.

Stroke (Hoboken, N.J.)·2026
Same author

Hemorrhage Evaluation and Detector System for Underserved Populations: HEADS-UP.

Mayo Clinic proceedings. Digital health·2025
Same author

Anagrelide in the management of essential thrombocythemia: a systemic review and meta-analysis.

International journal of hematology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Sep 23, 2025

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

7.8K

Malignancy and Endocarditis: Divulging Into the Intertwined Association.

Lakshmi Sree Pugalenthi1, Mahlika Ahmad2, Sanjana Reddy3

  • 1Internal Medicine, Ago Medical and Educational Center Bicol Christian College of Medicine, Legazpi City, PHL.

Cureus
|May 16, 2022
PubMed
Summary

Cancer patients face increased risk of infective endocarditis (IE) due to immunosuppression and other factors. Understanding IE mechanisms and risk factors is crucial for early detection and effective, individualized treatment strategies in cancer care.

Keywords:
colorectal cancer and endocarditisinfective endocarditismalignancy and endocarditismarantic endocarditisnon-bacterial thrombotic endocarditiss. anginosus endocarditisstreptococcus bovis endocarditis

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.2K
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

16.0K

Related Experiment Videos

Last Updated: Sep 23, 2025

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

7.8K
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.2K
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

16.0K

Area of Science:

  • Oncology
  • Infectious Diseases
  • Cardiology

Background:

  • Cancer is an immunosuppressive disorder.
  • Cancer patients are susceptible to systemic complications like thromboembolism and infective endocarditis (IE).
  • Multiple pathogenic mechanisms contribute to IE development in cancer patients.

Purpose of the Study:

  • To compile crucial mechanisms of IE in cancer patients.
  • To identify risk factors and existing treatment interventions for IE in this population.
  • To emphasize the importance of awareness for better screening and patient-oriented therapy.

Main Methods:

  • Literature review and compilation of existing data on IE in cancer patients.
  • Analysis of pathogenic mechanisms, risk factors, and treatment modalities.
  • Focus on identifying key elements for effective management.

Main Results:

  • Cancer-associated immunosuppression and thromboembolism are key factors.
  • Understanding diverse pathogeneses aids in risk factor delineation.
  • Physicians can better screen for red flags with increased awareness.

Conclusions:

  • Awareness of IE pathogeneses in cancer patients is vital.
  • Identifying risk factors and tailoring therapy improves outcomes.
  • Evidence-based treatment targeting causative organisms and immune status is essential.